Skip to main content

Table 4 Antifungal activity of bacterial crude extracts against pathogenic fungi and their zone of inhibition including the diameter of disc (5 mm), the sample size was 25 μg/mL per disc (5 μl) in disc diffusion assay

From: An assessment on the role of endophytic microbes in the therapeutic potential of Fagonia indica

Bacteria crude extracts Pathogenic fungi and growth inhibition zone*
M. mycosis MIC µg/mL A. flavus MIC µg/mL A. fumigatus MIC µg/mL A. niger MIC µg/mL
Enterobacter hormaechei 7.06 ± 0.846a 100 8.81 ± 1.24a 100 7.63 ± 1.17a 100 9.92 ± 0.93a 100
Stenotrophomonas maltophilia 9.12 ± 1.06a 100 10.58 ± 1.36b 100 10.04 ± 0.55a 100 16.74 ± 0.31c 12.5
Bacillus tequilensis 12.2 ± 1.48a 50 7.96 ± 0.86a 100 9.54 ± 0.70a 100 9.69 ± 0.84a 100
Erwinia sp. 6.37 ± 0.63a 100 6.25 ± 0.58a 100 7.86 ± 1.08a 100 7.27 ± 0.47a 100
Pantoea dispersa 9.05 ± 0.931a 100 6.46 ± 0.84a 100 7.8 ± 1.13a 100 11.08 ± 0.47a 50
Pantoea cypripedii 7.31 ± 1.21a 100 7.6 ± 0.59a 100 8.1 ± 1.39a 100 7.39 ± 0.55a 100
Enterobacter cloacae 10.2 ± 1.24a 100 11.10 ± 0.88b 50 10.12 ± 0.72a 100 6.14 ± 0.78a 100
Bacillus subtilis 10.1 ± 1.81a 100 7.24 ± 0.65a 100 9.08 ± 0.82a 100 8.11 ± 0.29a 100
Controls (amphotericin B) 21.2 ± 0.985 14.07 ± 1.07 29.77 ± 1.08 16.30 ± 1.75
  1. Letter a–c represent; a highly significant, b slightly significant and c non-significant difference from control at P < 0.05 by one-way ANOVA in the column
  2. * Values are mean ± SD of triplicate
\